Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement

Launched by EMORY UNIVERSITY · Jun 14, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to screen 9-month-old infants for autism and other developmental delays. Researchers are using a special mobile device that tracks where the baby looks, helping to measure their social engagement. The goal is to see if this eye-tracking method can accurately identify children who may need further evaluation for autism spectrum disorder.

To participate in this study, infants need to be between 8 and 10 months old and generally healthy, meaning they shouldn’t have any current illnesses that could affect the results, like a fever or eye infections. Parents or caregivers must also be able to give their permission for their child to take part. If you decide to join, your child will undergo a simple eye-tracking test, which is expected to be safe and non-invasive. This study is currently recruiting participants, and your involvement could help improve early screening methods for autism.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Infants between the chronological ages of 8-10 months;
• • Infants must be generally healthy with no acute illnesses likely to prevent successful or valid data collection (e.g., current vomiting, high fever, conjunctivitis affecting vision);
• • participants' parents/caregivers must be able to understand and voluntarily provide written informed consent.
• Exclusion Criteria:
• • - Children will be excluded if they have signs of acute illness likely to prevent successful or valid data collection (e.g., conjunctivitis affecting vision, current vomiting, or high fever).